TransMedics Group, Inc. (NASDAQ:TMDX) Q3 2024 Earnings Call Transcript
Operator: Good afternoon and welcome to the TransMedics Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Transmedics Group Inc. (TMDX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Driehaus Capital Richard Driehaus | 1,442,207 | $226,426,499 | -3% | 1.94% |
| 2. | GLG Partners Noam Gottesman | 345,320 | $54,215,240 | 0.14% | |
| 3. | Royce & Associates Chuck Royce | 297,198 | $46,660,086 | -2% | 0.42% |
| 4. | 22,500,000 | $41,533,650 | 0.7% | ||
| 5. | 17,000,000 | $31,407,951 | 0.02% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $62.00 | 2,500 | 13,693 | 2023-08-29 | Filing | ||
| $22.71 | 74,062 | Director | 302,893 | 2021-11-29 | Filing | |
| $22.14 | 25,938 | Director | 228,831 | 2021-11-29 | Filing | |
| $17.00 | 10,000 | Director | 10,000 | 2019-11-11 | Filing | |
| $16.00 | 33,333 | Director | 33,333 | 2019-05-06 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $90.04 | 1,458 | 20,843 | 2024-11-11 | Filing | ||
| $84.30 | 1,454 | 732 | 2024-11-05 | Filing | ||
| $83.35 | 5,296 | 2,186 | 2024-11-05 | Filing | ||
| $82.64 | 1,083 | 20,843 | 2024-11-01 | Filing | ||
| $135.04 | 300 | 61,643 | 2024-10-15 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,828,744 | $381,132,776 | 0.02% | |
| 2. | 2,550,255 | $201,291,602 | 0% | |
| 3. | 1,865,115 | $147,213,527 | 0% | |
| 4. | 1,525,819 | $120,433,000 | 0.13% | |
| 5. | 1,342,915 | $105,996,281 | 0.57% |
News See All
Strong Results and Raised Guidance Pushed TransMedics Group (TMDX) in Q2
Janus Henderson Investors, an investment management company, released its “Janus Henderson Enterprise Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
Here’s Why TransMedics Group (TMDX) Rose in Q2
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
Oppenheimer's Favorite Stocks For Next 12 Months: Top 32 Stock Picks
The tail end of August is appearing to turn a fresh page for Wall Street.
10 Best Organ Transplant and Diagnosis Stocks To Buy Now
In the dynamic landscape of healthcare, the importance of organ transplantation cannot be overstated.
TransMedics Group, Inc. (NASDAQ:TMDX) Q2 2024 Earnings Call Transcript
Operator: Good afternoon, and welcome to the TransMedics Second Quarter 2024 Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded for replay purposes.
TransMedics (TMDX) Rallied 104% in Q2
Headwaters Capital Management, an investment management company, released its second-quarter 2024 investor letter. A copy of the letter can be downloaded here.
TransMedics Group, Inc. (NASDAQ:TMDX) Q1 2024 Earnings Call Transcript
Operator: Good afternoon and welcome to the TransMedics First Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Jim Cramer’s Latest Lightning Round: 11 Stock Recommendations
In this article, we will take a detailed look at Jim Cramer’s Latest Lightning Round: 11 Stock Recommendations. For a quick overview of such stocks, read our article Jim Cramer’s Latest Lightning...
TransMedics Group, Inc. (NASDAQ:TMDX) Q4 2023 Earnings Call Transcript
TransMedics Group, Inc. beats earnings expectations. Reported EPS is $0.12, expectations were $-0.08. TransMedics Group, Inc.
Billionaire Hedge Funds
